- Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B.T., Qing, W., Packman, K., Myklebost, O., Heimbrook, D.C., Vassilev, L.T. Proc. Natl. Acad. Sci. U.S.A. (2006)